Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Long-Term Safety Study of Valoctocogene Roxaparvovec for Patients with Severe Hemophilia A

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium France Germany Italy Spain
  • Study on the Safety and Effects of BAY 2599023 (Peboctocogene Camaparvovec) for Adults with Severe Hemophilia A

    Not recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany The Netherlands
  • Study on Physical Activity and Joint Health in Patients Aged 12 and Older with Severe Hemophilia A Treated with Efanesoctocog Alfa for 24 Months

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Croatia Czechia France Germany +8
  • Study on the Safety and Effectiveness of SerpinPC for Patients with Severe Hemophilia A or B

    Not recruiting

    2 1 1
    Belgium Bulgaria France Germany Italy Poland +1
  • Study on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors

    Not recruiting

    3 1 1
    Investigated Drugs:
    Denmark Estonia France Germany Hungary Italy +5